Table 2 Baseline clinical and biochemical characteristics in subjects with high risk plaques in the MS group and non-MS group

Age (years), mean ± SD

62 ± 10.4

61 ± 11.5

0.288

Male, n (%)

169 (52)

188 (50)

0.577

BMI (kg/cm²), mean ± SD

26.8 ± 3.67

24.7 ± 3.35

0.032

Waist circumference (cm), mean ± SD

91.8 ± 6.80

88.7 ± 6.34

0.026

Hypertension, n (%)

220 (67.5)

219 (58.0)

0.010

Diabetes, n (%)

217 (66.6)

207 (54.8)

0.002

Hyperlipidemia, n (%)

204 (62.6)

199 (52.6)

0.010

FBG (mmol/L), mean ± SD

6.7 ± 2.66

6.3 ± 2.27

0.006

LDL (mmol/l), mean ± SD

3.5 ± 0.78

3.4 ± 0.85

0.248

TG (mmol/l), mean ± SD

1.8 ± 1.16

1.6 ± 0.33

0.020

HDL (mmol/l), mean ± SD

1.2 ± 0.99

1.4 ± 0.74

0.043

hsCRP (mg/l), mean ± SD

8.0 ± 2.72

7.1 ± 3.15

<0.001

 Hypertension, n (%)

141 (43.3)

154 (40.7)

0.501

 Diabetes, n (%)

123 (37.7)

118 (31.3)

0.069

 Hyperlipidemia, n (%)

81 (24.8)

76 (20.1)

0.132

 Aspirin, n (%)

173 (53.1)

177 (46.8)

0.112

 Statins, n(%)

94 (28.9)

93 (24.7)

0.231

 Positive remodeling, n (%)

216 (66.3)

205 (54.2)

0.001

 Low attenuation, n (%)

142 (43.6)

155 (41.0)

0.540

 Spotty calcification, n (%)

213 (65.3)

207 (54.8)

0.004

 Napkin ring sign, n (%)

165 (50.6)

154 (40.7)

0.010

 MACEs, n (%)

96 (29)

57 (15)

<0.001